Cargando…

2367. Infection Incidence and Utilization of Antimicrobials in Physician Office Infusion Centers (POICs)

BACKGROUND: POICs offer a controlled setting for safe and effective outpatient treatment of moderate to severe infections with intravenous antimicrobial agents (IVAA) and agents used in treatment of Clostridium difficile infection (CDI). These therapies are provided via in-office or home administrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Anglen, Lucinda J, Hardin, Thomas C, Schroeder, Claudia P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253161/ http://dx.doi.org/10.1093/ofid/ofy210.2020

Ejemplares similares

2494. Real-World Use of Ibalizumab in Physician Office Infusion Centers (POICs)
por: Prokesch, Richard C, et al.
Publicado: (2019)

1016. Real-World Use of Omadacycline in Physician Office Infusion Centers (POICs)
por: Van Anglen, Lucinda J, et al.
Publicado: (2022)

2380. Healthcare Resource Utilization for High-Risk Patients Treated With Dalbavancin in Physician Office Infusion Centers (POICs)
por: Luu, Quyen, et al.
Publicado: (2018)

597. The Impact of COVID-19 on Outpatient Intravenous Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers (POICs)
por: Martin, Clifford P, et al.
Publicado: (2021)

755 Comparison of Outpatient Antimicrobial Therapy (OPAT) in a Physician Office Infusion Center (POIC) vs Traditional Home Health Care (HHC)
por: Prokesch, Richard C., et al.
Publicado: (2014)

313. Outpatient Treatment and Recurrence of Prosthetic Joint Infection (PJI) in Infectious Disease (ID) Physician Office Infusion Centers (POICs): A 2-Year Retrospective Multicenter Analysis
por: Metzger, Brian S, et al.
Publicado: (2018)

763 Low Hospital Admission Rates Following Physician Office Infusion Center (POIC)-Based Outpatient Treatment with Intravenous Antibiotics (IVABs)
por: Alvarado, Fernando S., et al.
Publicado: (2014)

1625. Real-World Outpatient Utilization of Ceftolozane/Tazobactam in Physician Office Infusion Centers (OICs)
por: Van Anglen, Lucinda J, et al.
Publicado: (2020)

750. Serious Bacterial Infections: Successful Outpatient Management by Infectious Disease Physicians in Office Infusion Centers
por: Adams, John S, et al.
Publicado: (2019)

598. A 3-Year Evaluation of Antibiotic Resistance Patterns in Gram-Negative Genitourinary Tract Infections Treated in Outpatient Infusion Centers (POICs)
por: Hengel, Richard L, et al.
Publicado: (2021)

2081. Low 30-Day Hospital Readmission Rates in Medicare Patients Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers
por: Luu, Quyen, et al.
Publicado: (2019)

1854. Effective Antimicrobial Stewardship for Outpatient Parenteral Antimicrobial Therapy (OPAT): Nationwide Experience in Infectious Disease Physician Infusion Centers
por: Nathan, Ramesh V, et al.
Publicado: (2018)

1327. Vancomycin Dosing by AUC(24)/MIC in Comparison to Traditional Trough Dosing in Office Infusion Centers (OICs)
por: Luu, Quyen, et al.
Publicado: (2020)

501. Evaluation of Bezlotoxumab in Prevention of Recurrent C. difficile Infection: A Multicenter Single-Arm Study in Outpatient Infusion Centers
por: Hengel, Richard L, et al.
Publicado: (2018)

614. Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections and Bacteremia in Infectious Disease Outpatient Infusion Clinics
por: Metzger, Brian S, et al.
Publicado: (2020)

Successful Establishment of an Antimicrobial Stewardship Program (ASP) for Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Nathan, Ramesh V, et al.
Publicado: (2017)

2382. Recurrent Clostridioides difficile Infection (CDI) Worsens Anxiety-Related Patient-Reported Quality of Life
por: Garey, Kevin W, et al.
Publicado: (2019)

787. Evaluation of Clostridioides difficile Environmental Contamination Surrounding C. difficile Patients vs. non-C. difficile Patients in Outpatient Infusion Centers
por: Garey, Kevin W, et al.
Publicado: (2020)

610. Low Rates of Acute Kidney Injury (AKI) in Outpatient Vancomycin Managed by Pharmacists using Precision Dosing Software
por: Schroeder, Claudia P, et al.
Publicado: (2022)

Safety and Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Aged Population
por: Van Anglen, Lucinda J, et al.
Publicado: (2017)

2367. Selecting Testing Frequency for Estimation of Incubation Periods: A Simulation Study Based on Clostridioides difficile Observations
por: Wilson, Brigid, et al.
Publicado: (2019)

Synthesis of 2,3,6,7-tetrabromoanthracene
por: Schäfer, Christian, et al.
Publicado: (2008)

A Real-world Multicenter Outpatient Experience of Ceftolozane/Tazobactam
por: Van Anglen, Lucinda J, et al.
Publicado: (2023)

283. Antibiotic Utilization for Pneumonia and Other Respiratory Infections in Pediatricians’ Offices, Urgent Care Centers, and a Pediatric Emergency Department
por: Islam, Shamim, et al.
Publicado: (2018)

Utilization of Psychiatric Team Driven Ketamine Infusions
por: Ithman, M., et al.
Publicado: (2022)

2101. Impact of “Code Sepsis” on Antimicrobial Utilization at an Academic Medical Center
por: Kang, Minji, et al.
Publicado: (2019)

PReS-FINAL-2367: Academic training of pediatric rheumatologist in the Russian federation
por: Alekseeva, E, et al.
Publicado: (2013)

1344. Impact of Pharmacist-Physician Team on Antimicrobial Utilization at a Pediatric Hospital
por: Sapozhnikov, Julia, et al.
Publicado: (2020)

1547. Modeling Pharmacokinetics and Pharmacodynamics of Meropenem Utilizing a Novel Infusion Method of Bolus to Prolonged Infusion
por: Moore, Sarah E, et al.
Publicado: (2019)

1872. Antimicrobial Utilization Variability Among Training Services at an Academic Medical Center
por: Schulz, Lucas T, et al.
Publicado: (2018)

303. Evaluation of Antimicrobial Utilization and the Incidence of Bacterial Pneumonia Co-infection in Non-ICU COVID-19 Patients at an Urban Academic Medical Center
por: Groome, Sara, et al.
Publicado: (2021)

2,3,6,7-Tetrakis(bromomethyl)naphthalene
por: Skibiński, Maciej, et al.
Publicado: (2010)

PB2367: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH NODAL PERIPHERAL T-CELL LYMPHOMA
por: Yahia, Noura Ben, et al.
Publicado: (2023)

1851. Impact of an Antimicrobial Stewardship Initiative on Fluoroquinolone Utilization in the Outpatient Setting at an Academic Medical Center
por: Lafi, Yousef, et al.
Publicado: (2018)

2,3,6,7-Tetrabromo-9-butyl-9H-carbazole
por: Novina, J. Josephine, et al.
Publicado: (2012)

2,3,6,7-Tetramethoxy-9,10-anthraquinone
por: Ohta, Akira, et al.
Publicado: (2012)

2367. Six-month Humoral Response Following Two Or Three Doses Of Covid-19 Vaccines As Primary Vaccination Followed Or Not By a Booster Dose In Specific Populations – ANRS0001S COV-POPART Cohort Study
por: LOUBET, Paul, et al.
Publicado: (2023)

Tetramethyl anthracene-2,3,6,7-tetracarboxylate–tetramethyl 9,10-dihydro-9,10-dioxoanthracene-2,3,6,7-tetracarboxylate (1/1)
por: Drake, Brenton L., et al.
Publicado: (2012)

748 Outpatient Parenteral Antimicrobial Therapy (OPAT) with Continuous Infusions by Elastomeric Infusion Devices in Japan, as an Effective Tool for Better Antimicrobial Stewardship
por: Hase, Ryota, et al.
Publicado: (2014)

Impact of air pollution on physician office visits for common childhood conditions in Ontario, Canada
por: Feldman, Laura, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c5e8lplh1ubi6kkebdpt3nct5d